Sort
15,273 grants matching “antimicrobial resistance”
Novel gene-silencing therapeutics for multidrug-resistant gram-negative pathogens
$372,084David Elihu Greenberg · Ut Southwestern Medical Center · R33 · FY2014 · AI
Reciprocal control of motility and adherence in UTI
$372,038Harry L. Mobley · University Of Michigan At Ann Arbor · R01 · FY2012 · AI
Reciprocal control of motility and adherence in UTI
$372,037Harry L. Mobley · University Of Michigan At Ann Arbor · R01 · FY2011 · AI
Biological vector borne transmission of Salmonella by cockroaches
$372,005Jose Enrique Pietri · University Of South Dakota · R01 · FY2023 · AI
Role of AMP-activated protein kinase in bacterial endophthalmitis
$371,991Ashok Kumar · Wayne State University · R01 · FY2021 · EY
Role of the enterococcal site 2 protease in biofilm formation, adaptation, and host-pathogen interactions
$371,937Kristi L Frank · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2019 · AI
Role of the enterococcal site 2 protease in biofilm formation, adaptation, and host-pathogen interactions
$371,937Kristi L Frank · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2020 · AI
Biological vector borne transmission of Salmonella by cockroaches
$371,918Jose Enrique Pietri · University Of South Dakota · R01 · FY2024 · AI
Novel Bacterial Pathogens in Pelvic Inflammatory Disease
$371,917Catherine L Haggerty · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AI
Microbial and metabolomic profiling of the intestinal microenvironment distinguishing patients with mild and severe COVID-19 symptoms.
$371,859Suzanne Devkota · Cedars-Sinai Medical Center · R01 · FY2020 · DK
Mechanisms of host protection during infection via the mitochondrial unfolded protein response
$371,825Mark Watson Pellegrino · University Of Texas Arlington · R35 · FY2025 · GM
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core
$371,817Eleftherios Mylonakis · Miriam Hospital · P20 · FY2020 · GM
Application of Imaging to Development of Tuberculosis Interventions
$371,800Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R01 · FY2015 · AI
Application of Imaging to Development of Tuberculosis Interventions
$371,800Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R01 · FY2017 · AI
Application of Imaging to Development of Tuberculosis Interventions
$371,800Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R01 · FY2016 · AI
Genes Mediating Innate Immune Suppression by Hypercapnia in Mammals and Flies
$371,729Greg J Beitel · Northwestern University · R01 · FY2014 · HL
Development of antibacterial agents and materials
$371,699Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Investigating pharmacodynamics of antimicrobials against bacteria accumulating resistance
$371,699Derek Mosier · Kansas State University · R15 · FY2017 · GM
GLUCOCORTICOSTEROID ACTION IN INFLAMMATORY DISEASE
$371,537Robert P Schleimer · Northwestern University At Chicago · R01 · FY2008 · HL
Application of Nanogel-modified Resins for Improved Polymeric Dental Materials
$371,517Jeffrey W Stansbury · University Of Colorado Denver · R01 · FY2012 · DE
Targeting the Toxins: A Novel Non-Antimicrobial Approach to Combat Clostridium difficile infections
$371,500Charles Darkoh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2015 · AI
THE SALMONELLA TYPHIMURIUM SIGMAE REGULON
$371,495Ferric C Fang · University Of Washington · R01 · FY2009 · AI
THE SALMONELLA TYPHIMURIUM SIGMAE REGULON
$371,495Ferric C Fang · University Of Washington · R01 · FY2008 · AI
Molecular bssis of mef-mediated antibiotic resistance in Streptococcus pneumoniae
$371,481David S Stephens · Emory University · R01 · FY2010 · AI
Mechanisms and Applications of CRISPR-Cas Enzymes
$371,446M. Elizabeth Stroupe · Florida State University · R01 · FY2023 · GM